/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-11-14-05-22-574-66e1a3a2fd5f6342208d14c9.jfif)
The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-09-18-08-50-41-355-65080f616339aae19fcc0b02.jpg)
The quintessential right of a patentee is to exclusively exploit their invention (and authorise others to do so) during the term of the...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2023-04-13-15-19-57-516-64381d9df636ea1358fe2401.jpg)
ESG is increasingly a primary focus for companies and consumers alike. Across all industries, companies are under immense scrutiny from...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2021-06-20-22-57-41-873-60cfc7e5e5416a028865e9f7.jpg)
Summary In a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5a294fe83d947616fca6aa31/2020-10-22-15-57-24-723-5f91abe453548803c8ff38e1.JPG)
This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...
How far does the new doctrine of equivalents introduced by the UK Supreme Court in Eli Lilly v Actavis really extend the scope of patent...
